IGC Pharma, Inc.

IGCAMEXUSD
0.28 USD
0.00 (1.11%)AT CLOSE (11:59 AM EDT)
0.28
0.00 (1.27%)
POST MARKET (AS OF 05:47 PM EDT)
Post Market
AS OF 05:47 PM EDT
0.28
0.00 (1.27%)
🟢Market: OPEN

Shares of IGC Pharma, Inc. (IGC) are trading at $0.28. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, IGC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Sep 14, 2026.

Open?$0.28
High?$0.28
Low?$0.27
Prev. Close?$0.28
Volume?819.5K
Avg. Volume?884.5K
VWAP?$0.28
Rel. Volume?0.93x
Bid / Ask
Bid?$0.28 × 100
Ask?$0.28 × 500
Spread?$0.01
Midpoint?$0.28
Valuation & Ratios
Market Cap?28.9M
Shares Out?103.4M
Float?92.4M
Float %?92.3%
P/E Ratio?N/A
P/B Ratio?4.73
EPS?-$0.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Employees
70
Market Cap
28.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2006-04-13
Address
10224 FALLS ROAD
POTOMAC, MD 20854
Phone: 301-529-4996
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
10
Short Sent.?
95
Piotroski F-Score?1/9Weak
Altman Z-Score?-17.13Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.78%Low
Short Interest?724.8K
Days to Cover?1.0
Free Float92.4M
Avg Daily Volume1.1M
Settlement Date2026-08-31
Financial Health
Current Ratio?0.40Weak
Quick Ratio?0.18Weak
Cash Ratio?0.07Low
Debt/Equity?0.15Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
39
4.73FAIR
P/S?
Peers
100
S&P
3
22.18HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.4CHEAP
EV/Sales?
Peers
100
S&P
3
22.73HIGH
Returns & Efficiency
ROE?
S&P
3
-104.5%WEAK
ROA?
S&P
3
-69.6%WEAK
Cash Flow & Enterprise
FCF?$-4135000
Enterprise Value?$29.7M
Fundamentals ratios updated end of day